An introduction to instrumental variables analysis: Part 1

Neuroepidemiology

Volumn 35, Issue 3, 2010, Pages 237-240

  Bennett, Derrick A ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Controlled trials; Epidemiological methods; Statistics

Indexed keywords

ASCORBIC ACID;

ANGIOPLASTY; BYPASS SURGERY; CARDIOVASCULAR RISK; CONFOUNDING VARIABLE; EVIDENCE BASED PRACTICE; HEART CATHETERIZATION; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; MEDICAL LITERATURE; METHODOLOGY; OBSERVATIONAL STUDY; PATIENT TRANSPORT; SHORT SURVEY;

EFFECT MODIFIERS (EPIDEMIOLOGY); EVIDENCE-BASED MEDICINE; HUMANS; LEAST-SQUARES ANALYSIS; MODELS, STATISTICAL; OBSERVATION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN;

EID: 77956793524     PISSN: 02515350     EISSN: None     Source Type: Journal    
DOI: 10.1159/000319455     Document Type: Short Survey

References (26)

1. Black N: Why we need observational studies to evaluate the effectiveness of health care. BMJ 1996; 312: 1215-1218.
2. Grimes DA, Schulz KF: Bias and causal associations in observational research. Lancet 2002; 359: 248-252.
3. Grimes DA, Schulz KF: An overview of clinical research: the lay of the land. Lancet 2002; 359: 57-61.
4. Collins R, MacMahon S: Reliable assessment of the effects of treatment on mortality and major morbidity. I. Clinical trials. Lancet 2001; 357: 373-380. (Pubitemid 32128549)
5. Feigin V, Kurtzke JF, Korczyn A, Beghi E, Brown A: Bridging the gap between experimental and nonexperimental neuroepidemiology, and ultimately between neuroepidemiological research and practice: round table discussion at the First International Congress on Clinical Neurology and Epidemiology. Neuroepidemiology 2009; 33: 296-304.
6. Tatsioni A, Bonitsis NG, Ioannidis JP: Persistence of contradicted claims in the literature. JAMA 2007; 298: 2517-2526.
7. Osganian SK, Stampfer MJ, Rimm E, et al: Vitamin C and risk of coronary heart disease in women. J Am Coll Cardiol 2003; 42: 246-252. (Pubitemid 36851413)
8. Heart Protection Study Collaborative Group: MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo- controlled trial. Lancet 2002; 360: 23-33.
9. Lawlor DA, Davey Smith G, Kundu D, Bruckdorfer KR, Ebrahim S: Those confounded vitamins: what can we learn from the differences between observational versus randomised trial evidence? Lancet 2004; 363: 1724-1727.
10. Lawlor DA, Ebrahim S, Kundu D, Bruckdorfer KR, Whincup PH, Smith GD: Vitamin C is not associated with coronary heart disease risk once life course socioeconomic position is taken into account: prospective findings from the British Women's Heart and Health Study. Heart 2005; 91: 1086-1087.
11. Signorello LB, McLaughlin JK, Lipworth L, Friis S, Sorensen HT, Blot WJ: Confounding by indication in epidemiologic studies of commonly used analgesics. Am J Ther 2002; 9: 199-205.
12. MacMahon S, Collins R: Reliable assessment of the effects of treatment on mortality and major morbidity. II. Observational studies. Lancet 2001; 357: 455-462. (Pubitemid 32156151)
13. Angrist J, Krueger A: Instrumental variables and the search for identification: from supply and demand to natural experiments. J Econ Perspect 2001; 15: 69-85.
14. Greenland S: An introduction to instrumental variables for epidemiologists. Int J Epidemiol 2000; 29: 722-729.
15. Newhouse JP, McClellan M: Econometrics in outcomes research: the use of instrumental variables. Annu Rev Public Health 1998; 19: 17-34.
16. Wang PS, Schneeweiss S, Avorn J, et al: Risk of death in elderly users of conventional versus atypical antipsychotic medications. N Engl J Med 2005; 353: 2335-2341.
17. Klungel OH, Martens EP, Psaty BM, et al: Methods to assess intended effects of drug treatment in observational studies are reviewed. J Clin Epidemiol 2004; 57: 1223-1231.
18. Martens EP, Pestman WR, de Boer A, Belitser SV, Klungel OH: Instrumental variables: application and limitations. Epidemiology 2006; 17: 260-267.
19. Bound J, Jaeger DA, Baker R: Problems with instrumental variable estimation when the correlation between the instruments and endogenous explanatory variables is weak. J Am Stat Assoc 1995; 90: 443-450.
20. Cragg JG, Donald SG. Testing identifiability and specification in instrumental variable models. Econ Theory 1993; 9: 222-240.
21. Normand SL: Some old and some new statistical tools for outcomes research. Circulation 2008; 118: 872-884.
22. Permutt T, Hebel JR: Simultaneous-equation estimation in a clinical trial of the effect of smoking on birth weight. Biometrics 1989; 45: 619-622.
23. Rassen JA, Brookhart MA, Glynn RJ, Mittleman MA, Schneeweiss S: Instrumental variables. I. Instrumental variables exploit natural variation in nonexperimental data to estimate causal relationships. J Clin Epidemiol 2009; 62: 1226-1232.
24. Penrod JD, Goldstein NE, Deb P: When and how to use instrumental variables in palliative care research. J Palliat Med 2009; 12: 471-474.
25. Grootendorst P: A review of instrumental variables estimation of treatment effects in the applied health sciences. Health Serv Outcomes Res Methodol 2007; 7: 159-179.
26. Rassen JA, Brookhart MA, Glynn RJ, Mittleman MA, Schneeweiss S: Instrumental variables. II. Instrumental variable application - in 25 variations, the physician prescribing preference generally was strong and reduced covariate imbalance. J Clin Epidemiol 2009; 62: 1233-1241.